Although, as a known palmitoyl acyltransferase inhibitor, 2-BP is reported to have anti-tumor effect(38), it is weak and non-specific (IC50 is around 16 μM for DHHC7 in vitro)(24, 25). Here, ZDHHC7 is linked to neoplasm.